Multiple endocrine neoplasia type 2 differential diagnosis

Revision as of 21:05, 21 September 2015 by Ammu Susheela (talk | contribs) (Created page with "__NOTOC__ {{Multiple endocrine neoplasia type 2}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Differential Diagnosis== Multiple endocrine neoplasia type 2 must be differentiated f...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Multiple endocrine neoplasia type 2 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 2 from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Multiple endocrine neoplasia type 2 differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 2 differential diagnosis

CDC on Multiple endocrine neoplasia type 2 differential diagnosis

Multiple endocrine neoplasia type 2 differential diagnosis in the news

Blogs on Multiple endocrine neoplasia type 2 differential diagnosis

Directions to Hospitals Treating Multiple endocrine neoplasia type 2

Risk calculators and risk factors for Multiple endocrine neoplasia type 2 differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Differential Diagnosis

Multiple endocrine neoplasia type 2 must be differentiated from following hereditary diseases.

Disease Definition
Medullary thyroid carcinoma An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.
C-cell hyperplasia An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.
Pheochromocytoma An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.
VHL (von Hippel Lindau) syndrome An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.
Hereditary paraganglioma-pheochromocytoma syndrome An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.
Polycythemia and paraganglioma/pheochromocytoma An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.
Neurofibromatosis type 1 An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.
Multiple endocrine neoplasia type 4 (MEN 4) An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.
Multiple endocrine neoplasia type 1 (MEN 1) An autosomal dominant genetic disorder causing abnormal growth of blood vessels in different parts of the body.